BIOQUAL, Inc. BIOQ

Company Overview

BIOQUAL, Inc. is a privately held contract research organization (CRO) specializing in preclinical and nonclinical research, primarily within the infectious disease, immunology, and vaccine development sectors. The company provides outsourced research services to pharmaceutical companies, biotechnology firms, government agencies, and academic institutions, supporting drug and vaccine discovery, development, and regulatory submissions. BIOQUAL’s core value proposition is its integrated in vivo, in vitro, and analytical capabilities focused on translational infectious disease models.

The company’s primary revenue drivers are fee-for-service research contracts, including animal model development, efficacy testing, immunogenicity studies, and bioanalytical services. BIOQUAL is particularly recognized for its expertise in high-containment infectious disease models and its long-standing work with U.S. government agencies. Founded in 1981, BIOQUAL evolved from a small immunology-focused laboratory into a specialized CRO with deep experience in biodefense, emerging infectious diseases, and vaccine evaluation, maintaining a niche position rather than pursuing large-scale commercialization.